Wave Life Sciences (WVE) Return on Sales (2015 - 2026)

Wave Life Sciences' Return on Sales history runs 12 years deep, the most recent figure standing at 0.01% for Q1 2026.

• Quarterly Return on Sales rose 4.0% year-over-year to 0.01% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.02% (down 1.0% YoY) and the FY2025 annual result came in at 0.05%, down 4.0% from the prior year.
• Return on Sales was 0.01% for Q1 2026 at Wave Life Sciences, up from 0.06% in the prior quarter.
• Across five years, Return on Sales topped out at 0.0% in Q3 2023 and bottomed at 1.37% in Q3 2022.
• A 5-year average of 0.25% and a median of 0.03% in 2024 frame the typical range for Return on Sales.
• Annual changes were most pronounced in 2022 — Return on Sales slumped 137 bps — and 2023, when it surged 137 bps.
• Wave Life Sciences' Return on Sales stood at 0.35% in 2022, then soared by 98 bps to 0.01% in 2023, then slumped by 198 bps to 0.02% in 2024, then tumbled by 247 bps to 0.06% in 2025, then soared by 88 bps to 0.01% in 2026.
• Business Quant data shows WVE's Return on Sales at 0.01% in Q1 2026, 0.06% in Q2 2025, and 0.05% in Q1 2025.